HCC Staff update
We are very excited to announce the creation of the Director of Clinical Quality Assurance (CQA) position here at HCC and the promotion of Mr. Dan Beck into that role. Jim Hart, President and CEO of HCC, says this of the expansion,” I am very excited to have Dan lead HCC’s Clinical Quality team. Dan has an impressive resume of study monitoring and
Staff Spotlight: Ben Down Under
By Ben Blaylock
All photos copyrighted Ben Blaylock, © 2017 Ben Blaylock.
On December 9, 2017, I left San Antonio, Texas, for a work trip to New Zealand. Once the work was done, I tagged an additional 10 days on to my trip, rented a car, and set out on an adventure. Over those 10 days, I drove 3088 km, or 1918 miles exploring
Essential documents Deep Dive: Monitoring Reports
Hart’s Good Clinical Practice glossary series
Welcome back to the Hart GCP knowledge series. We have been reviewing essential documents that are typically generated before the clinical phase of the trial begins. We have looked specifically at the Investigator brochure, clinical protocol/protocol amendments, informed consent tracking, advertisements, and agreements. Now we will look at some key documents required once a clinical
HART’S HEALTHY NEW YEAR TIPS
By Dana Fletcher and guest author, Jodi Fletcher
Whether you make ‘resolutions’ or not, you can still start the New Year right with a few heart-healthy lifestyle changes. There is no better time to start making healthy lifestyle choices than right now.
Sometimes, we can feel overwhelmed by the many things we could or should do to improve our health. To combat that,
MESSAGE FROM THE PRESIDENT: LOOKING BACK TO LOOK FORWARD
Last year at this time, alongside the visions of sugarplums dancing in my head were thoughts of gratitude. As 2017 has progressed and now comes to a close, I am struck by what those visions have meant for me this year. Marcus Lemonis, CEO of Camping World, and host of the television show, The Profit, is famous
PATTI LAWRENCE IS PROMOTED TO SENIOR CRA
Four years ago, a voice from Patti Lawrence’s past called her cellphone. Jim Hart, Chief Executive Officer of Hart Clinical Consultants, needed someone with clinical experience working in a cardiac cath lab. From that one phone call, Patti began a new phase in her professional career as a Clinical Research Associate, initially filling device proctoring roles, but diligently
HART HEALTHY TIPS:
THE GREAT AMERICAN SMOKEOUT
Save the date Thursday, November 16th! The American Cancer Society holds a very important event that day, which can be the first day towards quitting smoking for many people.
It’s The Great American Smokeout!
According to the Centers for Disease Control and Prevention, approximately 36.5 million Americans (15.1% of all adults) smoke cigarettes. Smoking causes several life-threatening diseases such as cancer, stroke,
HCC NEWS: THE VERMONT CARDIAC NETWORK CONFERENCE
On September 28, 2017, HCC staff members Cheryl Calhoun and Stan Reaves attended the Vermont Cardiac Network (VCN) Conference held in picturesque Woodstock, Vermont. VCN was established in 1984 to assure cardiac health status of Vermonters and other nearby residents. It is a group of physicians and nurses committed to providing quality educational programs in cardiac care and networking
Vulnerable Populations: who are they?
This is the fourth in a series of articles about medical ethics. Our previous posts in this series included the basics of medical ethics, the difference between utilitarianism and deontology, and the Belmont Report.
Today we will review vulnerable populations. The idea of vulnerable populations falls under the ethical construct of respect for persons. Remember that this principle is about autonomy, where
Good Clinical Practice glossary series
Welcome back to the Hart GCP knowledge series. We have been reviewing essential documents that are typically generated before the clinical phase of the trial begins. We have looked specifically at the Investigator brochure, clinical protocol/protocol amendments, informed consent tracking, and the use of advertisements. Today we will be reviewing financial documents and insurance required prior to beginning a clinical trial.